ArticleResearch square2023

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.

Scott Gerber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.